|Landscape of somatic mutations in 560 breast cancer whole-genome sequences|
S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ...
Nature 534 (7605), 47-54, 2016
|miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors|
E Enerly, I Steinfeld, K Kleivi, SK Leivonen, MR Aure, HG Russnes, ...
PloS one 6 (2), e16915, 2011
|Pan-cancer analysis of whole genomes.|
S Hirano, L Yang, M Juul, CA Purdie, BP O'Neill, R Kabbe, ...
Nature 578 (DKFZ-2020-01051), 82-93, 2020
|Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors|
A Tahiri, SK Leivonen, T Lüders, I Steinfeld, M Ragle Aure, J Geisler, ...
Carcinogenesis 35 (1), 76-85, 2014
|Targeted exploration and analysis of large cross-platform human transcriptomic compendia|
Q Zhu, AK Wong, A Krishnan, MR Aure, A Tadych, R Zhang, DC Corney, ...
Nature methods 12 (3), 211-214, 2015
|Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c|
MK Nygren, C Tekle, VA Ingebrigtsen, R Mäkelä, M Krohn, MR Aure, ...
British journal of cancer 110 (8), 2072-2080, 2014
|Breast cancer quantitative proteome and proteogenomic landscape|
HJ Johansson, F Socciarelli, NM Vacanti, MH Haugen, Y Zhu, I Siavelis, ...
Nature communications 10 (1), 1-14, 2019
|Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors|
MR Aure, SK Leivonen, T Fleischer, Q Zhu, J Overgaard, J Alsner, ...
Genome biology 14 (11), 1-20, 2013
|Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome|
MR Aure, V Vitelli, S Jernström, S Kumar, M Krohn, EU Due, TH Haukaas, ...
Breast Cancer Research 19 (1), 1-18, 2017
|Molecular features of subtype-specific progression from ductal carcinoma in situ to invasive breast cancer|
R Lesurf, MR Aure, HH Mørk, V Vitelli, T Sauer, J Geisler, S Hofvind, ...
Cell reports 16 (4), 1166-1179, 2016
|Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins|
S Myhre, OC Lingjærde, BT Hennessy, MR Aure, MS Carey, J Alsner, ...
Molecular oncology 7 (3), 704-718, 2013
|LIMT is a novel metastasis inhibiting lnc RNA suppressed by EGF and downregulated in aggressive breast cancer|
A Sas‐Chen, MR Aure, L Leibovich, S Carvalho, Y Enuka, C Körner, ...
EMBO molecular medicine 8 (9), 1052-1064, 2016
|Metabolic clusters of breast cancer in relation to gene-and protein expression subtypes|
TH Haukaas, LR Euceda, GF Giskeødegård, S Lamichhane, M Krohn, ...
Cancer & metabolism 4 (1), 1-14, 2016
|Subtype‐specific micro‐RNA expression signatures in breast cancer progression|
VD Haakensen, V Nygaard, L Greger, MR Aure, B Fromm, IRK Bukholm, ...
International journal of cancer 139 (5), 1117-1128, 2016
|Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression data|
MR Aure, I Steinfeld, LO Baumbusch, K Liestøl, D Lipson, S Nyberg, ...
PloS one 8 (1), e53014, 2013
|Copy number gain of hsa-miR-569 at 3q26. 2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers|
P Chaluvally-Raghavan, F Zhang, S Pradeep, MP Hamilton, X Zhao, ...
Cancer Cell 26 (6), 863-879, 2014
|miRNA551b-3p activates an oncostatin signaling module for the progression of triple-negative breast cancer|
D Parashar, A Geethadevi, MR Aure, J Mishra, J George, C Chen, ...
Cell reports 29 (13), 4389-4406. e10, 2019
|Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer|
MR Aure, S Jernström, M Krohn, HKM Vollan, EU Due, E Rødland, ...
Genome medicine 7 (1), 1-17, 2015
|Excess of miRNA-378a-5p perturbs mitotic fidelity and correlates with breast cancer tumourigenesis in vivo|
S Winsel, J Mäki-Jouppila, M Tambe, MR Aure, S Pruikkonen, AL Salmela, ...
British journal of cancer 111 (11), 2142-2151, 2014
|miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer|
EM Lindholm, M Ragle Aure, MH Haugen, K Kleivi Sahlberg, ...
Molecular oncology 13 (10), 2278-2296, 2019